1. [O1–05–05]: AMYLOID‐PET CONCORDANCE OF ELECSYS® CSF BIOMARKER IMMUNOASSAYS FOR ALZHEIMER's DISEASE. (1st July 2017) Authors: Seibyl, John; Shaw, Leslie M.; Blennow, Kaj; Widmann, Monika; Corradini, Veronika; Wahl, Simone; Zink, Katharina; Buck, Katharina; Eichenlaub, Udo; Hansson, Oskar Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 4 Page Start: P199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P3‐267: ANALYSIS OF CEREBROSPINAL FLUID (CSF) BIOMARKERS TO PREDICT RISK OF CLINICAL DECLINE AND PROGRESSION TO DEMENTIA IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND MILD COGNITIVE SYMPTOMS. (1st July 2006) Authors: Shaw, Leslie M.; Blennow, Kaj; Buck, Katharina; Eichenlaub, Udo; Lifke, Valeria; Widmann, Monika; Simon, Maryline; Hansson, Oskar Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 22 Page Start: P1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗